港股異動 | 比亞迪電子升超3%續創新高,獲花旗上調目標價162%
uSMART友信智投8月7日消息,週五港股,比亞迪電子延續近期升勢,截至9:47分,比亞迪電子升2.98%,報32.85港元,盤中最高觸及32.95港元,升幅高達3.13%。再創歷史新高。
花旗認為,儘管近期比亞迪電子的股價上升,仍未充分體現公司長期可持續的口罩業務帶來的價值,因此上調比亞迪電子的目標價162%至38港元。
分析師Andre Lin等在報告中寫道,比亞迪電子已經是世界上最大的口罩生產商之一,而且口罩通過FDA批准。
將公司2020和2021年的EPS預期分別上調162%和76%,維持買入評級。
與此同時,公司的核心業務運行良好,預計能夠承受華為受限帶來的不確定性影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.